Gerhardt Andrea, Scharf Rüdiger E, Zotz Rainer B
Department of Hemostasis and Transfusion Medicine, Heinrich Heine University Medical Center, Dusseldorf, Germany.
Thromb Haemost. 2003 Jul;90(1):77-85.
In a retrospective study of 190 women with a first history of venous thromboembolism during pregnancy and the puerperium and 190 age-matched women with at least one prior pregnancy and no history of venous thromboembolism, the individual probability of thrombosis was determined. Assuming an overall risk of 1 in 1500 pregnancies, the probability of pregnancy-related thrombosis in carriers of homozygous factor V Leiden was 1 in 80 (odds ratio 20.6, p=0.005) and among carriers of combined heterozygous factor V Leiden and heterozygous G20210A mutation in the prothrombin gene 1 in 20 (odds ratio 88, p<0.001). The probability of thrombosis per pregnancy among women with elevated levels of factor VIII:C (>172 % activity) was 1 in 385 (odds ratio 4.5, p<0.001) and among those with increased levels of von Willebrand factor antigen (>190 %) 1 in 435 (odds ratio 4.0, p=0.002), independent of elevated factor VIII:C levels. The high prevalence of combined and homozygous defects of hemostatic components (21.6%) in patients as compared with normal women (0.86%) supports the concept that venous thromboembolism is a multicausal disorder.
在一项回顾性研究中,对190名有孕期和产褥期首次静脉血栓栓塞病史的女性以及190名年龄匹配、至少有一次既往妊娠且无静脉血栓栓塞病史的女性进行研究,确定了个体血栓形成的概率。假设每1500次妊娠中总体风险为1例,纯合子凝血因子V莱顿突变携带者发生与妊娠相关血栓形成的概率为80分之一(比值比20.6,p = 0.005),在凝血因子V莱顿杂合子与凝血酶原基因G20210A杂合子联合突变携带者中为20分之一(比值比88,p < 0.001)。凝血因子VIII:C水平升高(活性>172%)的女性每次妊娠发生血栓形成的概率为385分之一(比值比4.5,p < 0.001),血管性血友病因子抗原水平升高(>190%)的女性为435分之一(比值比4.0,p = 0.002),且与凝血因子VIII:C水平升高无关。与正常女性(0.86%)相比,患者中止血成分联合和纯合缺陷的高患病率(21.6%)支持静脉血栓栓塞是一种多因素疾病的概念。